Literature DB >> 33646859

Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Elizabeth A Jacobsen1, David J Jackson2,3, Enrico Heffler4,5, Sameer K Mathur6, Albert J Bredenoord7, Ian D Pavord8, Praveen Akuthota9, Florence Roufosse10, Marc E Rothenberg11.   

Abstract

The enigmatic eosinophil has emerged as an exciting component of the immune system, involved in a plethora of homeostatic and inflammatory responses. Substantial progress has been achieved through experimental systems manipulating eosinophils in vivo, initially in mice and more recently in humans. Researchers using eosinophil knockout mice have identified a contributory role for eosinophils in basal and inflammatory processes and protective immunity. Primarily fueled by the purported proinflammatory role of eosinophils in eosinophil-associated diseases, a series of anti-eosinophil therapeutics have emerged as a new class of drugs. These agents, which dramatically deplete eosinophils, provide a valuable opportunity to characterize the consequences of eosinophil knockout humans. Herein, we comparatively describe mouse and human eosinophil knockouts. We put forth the view that human eosinophils negatively contribute to a variety of diseases and, unlike mouse eosinophils, do not yet have an identified role in physiological health; thus, clarifying all roles of eosinophils remains an ongoing pursuit.

Entities:  

Keywords:  IL-5; biologic agents; eosinophil; eosinophil knockout; eosinophil-associated diseases; eosinophil-deficient mice

Mesh:

Substances:

Year:  2021        PMID: 33646859      PMCID: PMC8317994          DOI: 10.1146/annurev-immunol-093019-125918

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  262 in total

1.  Studies on red cell aplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei.

Authors:  S B Krantz; V Kao
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

Review 2.  IgA Function in Relation to the Intestinal Microbiota.

Authors:  Andrew J Macpherson; Bahtiyar Yilmaz; Julien P Limenitakis; Stephanie C Ganal-Vonarburg
Journal:  Annu Rev Immunol       Date:  2018-01-26       Impact factor: 28.527

3.  Immunology in the Era of Single-Cell Technologies.

Authors:  Mirjana Efremova; Roser Vento-Tormo; Jong-Eun Park; Sarah A Teichmann; Kylie R James
Journal:  Annu Rev Immunol       Date:  2020-02-19       Impact factor: 28.527

4.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

Review 5.  The role of interleukin-5 (IL-5) in vivo: studies with IL-5 deficient mice.

Authors:  K I Matthaei; P Foster; I G Young
Journal:  Mem Inst Oswaldo Cruz       Date:  1997       Impact factor: 2.743

6.  Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.

Authors:  Jennifer K Garrett; Sean C Jameson; Blythe Thomson; Margaret H Collins; Lynne E Wagoner; Debbie K Freese; Lisa A Beck; Joshua A Boyce; Alexandra H Filipovich; Joyce M Villanueva; Steven A Sutton; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2003-12-12       Impact factor: 10.793

7.  Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus.

Authors:  Matthew G Drake; Elizabeth R Bivins-Smith; Becky J Proskocil; Zhenying Nie; Gregory D Scott; James J Lee; Nancy A Lee; Allison D Fryer; David B Jacoby
Journal:  Am J Respir Cell Mol Biol       Date:  2016-09       Impact factor: 6.914

8.  Activated Eosinophils Exert Antitumorigenic Activities in Colorectal Cancer.

Authors:  Hadar Reichman; Michal Itan; Perri Rozenberg; Tal Yarmolovski; Eli Brazowski; Chen Varol; Nathan Gluck; Shiran Shapira; Nadir Arber; Udi Qimron; Danielle Karo-Atar; James J Lee; Ariel Munitz
Journal:  Cancer Immunol Res       Date:  2019-01-21       Impact factor: 11.151

9.  Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers.

Authors:  Andrew Menzies-Gow; Sun Ying; Ian Sabroe; Victoria L Stubbs; Dulce Soler; Timothy J Williams; A Barry Kay
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

10.  Emerging roles of eosinophils and eosinophil-derived lipid mediators in the resolution of inflammation.

Authors:  Yosuke Isobe; Taiga Kato; Makoto Arita
Journal:  Front Immunol       Date:  2012-08-28       Impact factor: 7.561

View more
  15 in total

Review 1.  Eosinophil-lymphocyte interactions in the tumor microenvironment and cancer immunotherapy.

Authors:  Sharon Grisaru-Tal; Marc E Rothenberg; Ariel Munitz
Journal:  Nat Immunol       Date:  2022-08-24       Impact factor: 31.250

Review 2.  Solving the Conundrum of Eosinophils in Alloimmunity.

Authors:  Cherie Alissa Lynch; Yizhan Guo; Zhongcheng Mei; Daniel Kreisel; Andrew E Gelman; Elizabeth A Jacobsen; Alexander Sasha Krupnick
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

Review 3.  Initiation and Pathogenesis of Severe Asthma with Fungal Sensitization.

Authors:  Meenakshi Tiwary; Amali E Samarasinghe
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

4.  Transcriptional Profiling of Mouse Eosinophils Identifies Distinct Gene Signatures Following Cellular Activation.

Authors:  Avishay Dolitzky; Guy Shapira; Sharon Grisaru-Tal; Inbal Hazut; Shmulik Avlas; Yaara Gordon; Micahl Itan; Noam Shomron; Ariel Munitz
Journal:  Front Immunol       Date:  2021-12-14       Impact factor: 7.561

5.  A lesson from the wild: The natural state of eosinophils is Ly6Ghi.

Authors:  Iris Mair; Andrew Wolfenden; Ann E Lowe; Alex Bennett; Andrew Muir; Hannah Smith; Jonathan Fenn; Janette E Bradley; Kathryn J Else
Journal:  Immunology       Date:  2021-09-15       Impact factor: 7.397

Review 6.  Pulmonary Eosinophils at the Center of the Allergic Space-Time Continuum.

Authors:  Sjoerd T T Schetters; Martijn J Schuijs
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

Review 7.  A pragmatic guide to choosing biologic therapies in severe asthma.

Authors:  Joanne E Kavanagh; Andrew P Hearn; David J Jackson
Journal:  Breathe (Sheff)       Date:  2021-12

Review 8.  Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity.

Authors:  Peter Valent; Lina Degenfeld-Schonburg; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Hans-Uwe Simon; Andreas Reiter; Bruce S Bochner
Journal:  Semin Immunopathol       Date:  2021-05-30       Impact factor: 9.623

9.  Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.

Authors:  Marcela Valverde-Monge; José A Cañas; Blanca Barroso; Diana Betancor; Laura Ortega-Martin; Alicia Gómez-López; María Jesús Rodríguez-Nieto; Ignacio Mahíllo-Fernández; Joaquín Sastre; Victoria Del Pozo
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

Review 10.  Eosinophils and Bacteria, the Beginning of a Story.

Authors:  Edna Ondari; Esther Calvino-Sanles; Nicholas J First; Monica C Gestal
Journal:  Int J Mol Sci       Date:  2021-07-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.